Skip to main content

KE Holdings Inc. Announces First Quarter 2026 Unaudited Financial Results

BEIJING, May 19, 2026 (GLOBE NEWSWIRE) — KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE; HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, today announced its unaudited financial results for the first quarter ended March 31, 2026. Business and Financial Highlights for the First Quarter 2026Gross transaction value (GTV)1 was RMB711.7 billion (US$103.2 billion), a decrease of 15.6% year-over-year. GTV of existing home transactions was RMB534.4 billion (US$77.5 billion), a decrease of 7.9% year-over-year. GTV of new home transactions was RMB145.9 billion (US$21.2 billion), a decrease of 37.2% year-over-year. Net revenues were RMB18.9 billion (US$2.7 billion), a decrease of 19.0% year-over-year. Net income was RMB1,255 million (US$182 million), an increase of 46.7% year-over-year....

Continue reading

Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results

CARLSBAD, Calif., May 19, 2026 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $4.3 million, or $0.72 per diluted share, on net sales of $35.5 million for the third quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the third quarter of the prior fiscal year. Net sales during the three months ended March 31, 2026, increased $6.7 million, or 23%, to $35.5 million as compared to $28.8 million recorded in the comparable prior year period. During the same period, private-label contract manufacturing sales increased 25% to $33.8 million, primarily due to increased orders from one of our largest customers and shipments to new...

Continue reading

Resilient first quarter revenue growth amid global uncertainty

Report on first quarter of 2026for ROCKWOOL A/SRelease no. 16 – 2026to Nasdaq Copenhagen 19 May 2026 Resilient first quarter revenue growth amid global uncertainty Highlights1Demonstrating resilient growth despite continued geopolitical turbulence and unusual weather conditions in Europe and North America, revenue in Q1 2026 reached 906 MEUR, an increase of two percent measured in local currencies and flat in reported figures compared to last year. We expect that energy and raw material cost levels will remain elevated. To protect margins, we have implemented additional price increases in the range of 6-8 percent, with main impact from the middle of the year. EBITDA in Q1 2026 reached 187 MEUR, with a 20.7 percent EBITDA margin, a good result although down 2.1 percentage points compared to the record high quarter last year. The production...

Continue reading

Hesai Group Reports First Quarter 2026 Unaudited Financial Results

Quarterly net revenues were RMB680.6 million (US$98.7 million)1 Quarterly lidar shipments were 471,723 units Quarterly net income was RMB18.3 million (US$2.7 million) SHANGHAI, China, May 19, 2026 (GLOBE NEWSWIRE) — Hesai Group (“Hesai” or the “Company”) (NASDAQ: HSAI; HKEX: 2525), a global tech company and a leader in 3D perception, today announced its unaudited financial results for the three months ended March 31, 2026. Management Remarks “We are incredibly honored and excited to announce that Hesai serves as strategic lidar partner and confirmed supplier for Mercedes-Benz models enabling L3 autonomy. Meanwhile, the first quarter of 2026 marked a transformative chapter for Hesai as we began our strategic evolution from ‘Spatial Perception’ to ‘Spatial Intelligence.’ We are no longer just a global leader in lidar; we are building...

Continue reading

Unaudited Preliminary Results for the Year Ended December 31, 2025

LONDON and PHILADELPHIA, May 19, 2026 (GLOBE NEWSWIRE) — Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION, a tumor-activated oncology delivery platform today published its unaudited preliminary results for the 12 months ended December 31, 2025 (“FY25”). FY25 Highlights Research & Development (R&D) HighlightsIncreased momentum and strengthened position as a pure-play oncology biopharmaceutical company by focusing on the Company’s unique proprietary pre|CISION® peptide drug conjugate platform, with significant progress in R&D programsGen Two (AVA6103):First patient received treatment in FOCUS-01, a multicenter, open-label Phase 1 clinical trial of AVA6103 (FAP-Exd, pre|CISION®-enabled exatecan) – March 2026. The FOCUS-01...

Continue reading

CMB.TECH announces Q1 2026 results

CMB.TECH ANNOUNCES Q1 2026 RESULTSFIRING ON ALL CYLINDERS ANTWERP, Belgium, 19 May 2026 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) reported its unaudited financial results today for the first quarter ended 31 March 2026. HIGHLIGHTS Financial highlights:Profit for the period of USD 368.8 million in Q1 2026. EBITDA for the same period was USD 558.3 million. CMB.TECH’s contract backlog increased to USD 3.26 billion with the addition of 1 x 5-year Suezmax time charter and extension of 2 x Suezmax time charters by one year to a 10-year time charter each (with a profit split). Intention to distribute an amount of USD 0.64 per share.Fleet highlights:Delivery of 7 newbuilding vessels (Q1 + Q2 to date):Newcastlemaxes: Mineral Latvija VLCCs: Eburones, Menapii Suezmaxes:...

Continue reading

AMC Robotics Reports First Quarter 2026 Financial Results

Reports Net Income of $146K in First Quarter 2026, Compared to Net Loss in Prior-Year Period; Gross Margin Expands to 86% NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) — AMC Robotics Corporation (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), an AI-driven robotics solutions provider, today reported financial results for the three months ended March 31, 2026. “This quarter, we made meaningful progress across our robotics platforms. We transitioned NovaArm™ from development into a live warehouse environment through our strategic collaboration with Sunward Logistics, marking an important step toward commercialization,” said Sean Da, Chairman of the Board and Chief Executive Officer of AMC Robotics. “At the same time, we continued to build market awareness for Kyro™, and the interest generated at CES and Tokyo Security Show...

Continue reading

Pyxis Tankers Announces Financial Results for the Three Months Ended March 31, 2026

Maroussi, Greece, May 18, 2026 – Pyxis Tankers Inc. (Nasdaq Cap Mkts: PXS), (the “Company”, “we”, “our”, “us” or “Pyxis Tankers”), an international diversified shipping company, today announced unaudited results for the three months ended March 31, 2026. For the three months ended March 31, 2026, our revenues, net, were $10.0 million, compared to $9.6 million for the same period in 2025. During the first quarter of 2026, our time charter equivalent (“TCE”) revenues were $9.9 million, an increase of $1.5 million, or 18.2%, over the comparable period in 2025. Our net income attributable to common shareholders and available to common shareholders for the first quarter ended March 31, 2026 was $2.4 million, compared to net income of $0.8 million for the same period in 2025. For the first quarter of 2026, net income per common share was $0.23...

Continue reading

Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update

– Groundbreaking interim results from U.S. REGAIN trial in recurrent glioblastoma demonstrate 100% local disease control, 67% complete response rate, and favorable safety profile – – Completion of patient enrollment in the U.S. pivotal ReSTART trial in recurrent cutaneous squamous cell carcinoma, the Company’s first U.S. pivotal study – – Pooled data from two pancreatic cancer trials presented at Digestive Disease Week (DDW) 2026 demonstrated 100% local disease control and favorable safety, the first oral presentation of Alpha DaRT® pancreatic data at a premier international gastroenterology conference – – Abstracts accepted for presentation at the 2026 ASCO Annual Meeting and at the AHNS 12th International Conference on Head and Neck Cancer, reflecting growing scientific recognition across multiple...

Continue reading

project44 Delivers 34% New ARR Growth Fueled by AI Agent Momentum and Intelligent TMS Expansion

Shipper new ARR surges 52% year over year as enterprise logistics leaders deepen commitment to the Decision Intelligence Platform CHICAGO, May 18, 2026 (GLOBE NEWSWIRE) — project44, the Decision Intelligence Platform for the modern supply chain, today announced Q1 FY27 results: 34% year-over-year growth in new Annual Recurring Revenue (ARR), achieving 109% of plan. Multi-year deals drove 67% of new ARR, reflecting continued momentum in long-term customer commitments. Shipper New ARR grew 52% year over year, the fastest-growing segment in the business, and Shipper NRR improved approximately 300 basis points quarter over quarter, one of the largest single-quarter retention improvements in company history. Sustained NRR improvement and back-to-back plan overperformance are indicators that customers are embedding project44 deeper into...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.